Sign inSubmit
ArticleMetrics
Research Article · Free to read · Published 20 February 2012

Study on Survival of Chlamydia trachomatis in the Presence of Antichlamydial Drugs

Apurb Rashmi Bhengraj1, Pragya Srivastava1, Harsh Vardhan1, Suraj Singh Yadav1, Laishram Chandreshwor Singh1 & Aruna Mittal1

American Journal of Infectious Diseases, Volume 8, Issue 1, pp. 5–12 · doi.org/10.3844/ajidsp.2012.5.12

7,768 accesses5,674 downloads0 citations (Crossref)Metrics
Cite Check for updates

Abstract

Problem statement: Recurrent genital Chlamydia trachomatis infections due to treatment failures may results in complex sequelae leading to reproductive complexity and morbidity. It can be resulted by the heterotypic resistance with decreased drug susceptibility characteristic of the isolate. Studies are needed to understand the treatment failures and resistance characteristic of C. trachomatis. Hence, in vitro study was conducted on C. trachomatis isolate in the presence of antichlamydial drugs. Approach: Our aim was to study ygeD gene in C. trachomatis clinical isolate having decreased drug susceptibility profile and to analyze HeLa cells phenotypically upon infection in presence of antichlamydial drugs. Sequencing was done to check any mutational change (s) in ygeD gene of C. trachomatis isolate (CT-244), mRNA expression was analyzed in presence of antichlamydial drugs by Real Time RT-PCR. Transduction study was carried out in infected HeLa cells to detect changes at cellular level in presence of antichlamydial drugs by transducing with GFP/RFP-tagged proteins and analyzed by FACS. Results: A point mutation was detected in ygeD gene of C. trachomatis isolate. Further, mRNA expression level of ygeD gene was observed to be increased at 8 hpi in presence of doxycycline while in presence of azithromycin it was increased at 24 hpi. GFP-tagged plasma membrane protein expression in infected HeLa cells found to be reduced as compare to the uninfected cells. Upon infection, the RFP-tagged actin protein expression was up-regulated in comparison to the uninfected HeLa cells. No difference in expression of plasma membrane and actin protein was observed in susceptible serovar D and CT-244 isolate. Conclusion: The present study suggest that C. trachomatis isolate with decreased drug susceptibility profile may have an active efflux strategy for its survival in the presence of antichlamydial drugs and it may not affect its host cell plasma membrane or actin organization for its survival in order to resist the antichlamydial drugs.

Licence and reuse

Free to read. This article carries the publisher’s copyright, as printed on it: © 2012 Science Publications. It is free to read; ask us before reusing it.

How to reuse this article

Responses (0)

Have a comment on this research? Sign in to respond. Responses are moderated and published with your name and affiliation; the authors are invited to reply. How we use your dataWrite a response

About this article

Cite this article

Bhengraj, A. R., Srivastava, P., Vardhan, H., Yadav, S. S., Singh, L. C. & Mittal, A. (2012). Study on Survival of Chlamydia trachomatis in the Presence of Antichlamydial Drugs . American Journal of Infectious Diseases, 8(1), 5–12. https://doi.org/10.3844/ajidsp.2012.5.12

Licence
© Science Publications
Issue
Volume 8, Issue 1
Policies
Editorial independenceUse of generative AIData availabilityAppeals and complaints
Version
Version of record
Study on Survival of Chlamydia trachomatis in the Presence of Antichlamydial DrugsAmerican Journal of Infectious Diseases · Volume 8, Issue 1 · pp. 5–12 · © Science PublicationsDownload